Bacterial reprogramming of PBMCs impairs monocyte phagocytosis and modulates adaptive T cell responses. (Q54340193)

28 May 2018

title

Bacterial reprogramming of PBMCs impairs monocyte phagocytosis and modulates adaptive T cell responses. (English)

1 reference

28 May 2018

1 reference

Maya C André

1

1 reference

28 May 2018

Christian Gille

2

1 reference

28 May 2018

Philip Glemser

3

1 reference

28 May 2018

Jeanette Woiterski

4

1 reference

28 May 2018

Hsin-Yun Hsu

5

1 reference

28 May 2018

Baerbel Spring

6

1 reference

28 May 2018

Hildegard Keppeler

7

1 reference

28 May 2018

Boris W Kramer

8

1 reference

28 May 2018

Rupert Handgretinger

9

1 reference

28 May 2018

Christian F Poets

10

1 reference

28 May 2018

Kirsten Lauber

11

1 reference

28 May 2018

Thorsten W Orlikowsky

12

1 reference

28 May 2018

publication date

16 March 2012

1 reference

28 May 2018

Journal of Leukocyte Biology

published in

1 reference

28 May 2018

volume

91

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

page(s)

977-989

1 reference

28 May 2018

Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Different modes of IL-10 and TGF-beta to inhibit cytokine-dependent IFN-gamma production: consequences for reversal of lipopolysaccharide desensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Dysregulation of in vitro cytokine production by monocytes during sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Phagocytosis and postphagocytic reaction of cord blood and adult blood monocyte after infection with green fluorescent protein-labeled Escherichia coli and group B Streptococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

A new method to quantify phagocytosis and intracellular degradation using green fluorescent protein-labeled Escherichia coli: comparison of cord blood macrophages and peripheral blood macrophages of healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Construction of versatile high-level expression vectors for Bartonella henselae and the use of green fluorescent protein as a new expression marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Miniaturized parallelized sandwich immunoassays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Migration to apoptotic "find-me" signals is mediated via the phagocyte receptor G2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Diminished phagocytosis-induced cell death (PICD) in neonatal monocytes upon infection with Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

The pathophysiology and treatment of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Immunomodulatory therapies in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Stereotyped and specific gene expression programs in human innate immune responses to bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Human macrophage activation programs induced by bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

The biological functions of T helper 17 cell effector cytokines in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

Th17 (IFNγ- IL17+) CD4+ T cells generated after burn injury may be a novel cellular mechanism for postburn immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0911474

21 January 2018

Identifiers

DOI

10.1189/JLB.0911474

1 reference

28 May 2018

PubMed ID

22427683

1 reference

28 May 2018